Search the Newsreel

Clover Health Eyes 2026 GAAP Profit as AI Platform Fuels Medicare Advantage Growth

Key Points Interested in Clover Health Investments, Corp.? Here are five stocks we like better. Clover Health is targeting its first full year of GAAP profitability in 2026, alongside approximately 50% membership growth, after reporting sustained adjusted EBITDA profitability and improved operating leverage. The …

AppLovin Shares Slip as Post-Earnings Pressure Lingers

Clover Health Investments (NASDAQ:CLOV) Shares Down 4.7% After Insider Selling

AppLovin Corporation (APP) Stock Price, News, Quote & History

AppLovin Corporation (APP) experienced a significant overnight drop of 16.23% after its stock closed at $417.80. This decline follows recent Q2 2026 earnings reports that missed revenue estimates and soft guidance, despite some sources noting that the company "Tops Q2 Earnings Estimates" and still …

¿Está AppLovin (APP) Infravalorada Tras Sus Resultados Y Las Dudas Sobre Su IA?

Clover Health CEO Andrew Toy sells $408,260 in stock By Investing.com

Clover Health CEO Andrew Toy sold 87,798 shares of the company's Class A Common Stock for approximately $408,260. This "sell to cover" transaction was not discretionary but mandated to fulfill tax withholding obligations tied to previously granted restricted stock units. Following this, Mr. Toy …

CLOV (Nasdaq: CLOV) discloses planned 85,704-share sale by Andrew Toy

Clover Health Investments, Corp. (Nasdaq: CLOV) has disclosed a planned sale of 85,704 shares of Class A common stock by Andrew Toy through Morgan Stanley Smith Barney LLC, valued at approximately $391,667.28. These shares originate from Restricted Stock Units acquired as compensation on August …

Clover Health (CLOV) CEO Andrew Toy sells 87,798 shares for tax withholding

Clover Health CEO Andrew Toy sold 87,798 shares of Class A Common Stock for $408K on August 10, 2026, at a weighted average price of $4.65 per share. This sale was non-discretionary and conducted solely to cover tax withholding obligations associated with the final …

Weekly Recap: Axon AI expands beyond mobile and Q2 EPS, $551.3M buyback

AppLovin Corp. (NASDAQ:APP) is expanding its Axon AI from mobile gaming into broader digital advertising markets like e-commerce and web performance marketing. The company reported Q2 2026 EPS of $3.77 (basic) and $3.76 (diluted). Additionally, AppLovin repurchased 1.1 million Class A shares for $551.3 …

APP Stock Falls 17% Since Q2 Earnings: Is it a Buy After the Pullback?

AppLovin APP reported second-quarter 2026 results on Aug. 5, and a few trading sessions have provided a clearer view of how investors are digesting the report. The stock has declined roughly 17% since the earnings release, suggesting that the market has focused less on …

Dimensional Fund Advisors LP Lowers Stake in The Lovesac Company $LOVE

Dimensional Fund Advisors LP reduced its holdings in The Lovesac Company (NASDAQ:LOVE) by 13.1% in the first quarter, selling 88,758 shares but still retaining 587,699 shares valued at $8.68 million. Despite this, institutional investors and hedge funds own a significant 91.32% of the company's …

AppLovin Earnings Call Shows Profitable Growth Momentum

AppLovin's Q2 earnings call highlighted significant revenue growth, robust adjusted EBITDA, and strong free cash flow, along with a focus on shareholder returns through buybacks. Despite acknowledging some execution hiccups and rising compute costs, management expressed confidence in sustained high profitability and an optimistic …

AppLovin Revenue Jumped 53%. So Why Did the Stock Just Plunge 20%?

Key Points AppLovin's revenue growth was strong but slightly missed expectations. Following the sell-off, the stock is cheap again. 10 stocks we like better than AppLovin › Investors weren't loving AppLovin's (NASDAQ: APP) Q2 results, and a difficult year for the stock just got …

Clover Health (CLOV) Is Up 14.1% After Raising 2026 Profit Outlook And Returning To Net Income

Por qué AppLovin (APP) ha caído un 12,4 % tras unos resultados espectaculares en el segundo trimestre, la recompra de acciones y las aclaraciones de la SEC, y qué se prevé para el futuro

Asian Dividend Stocks: Plover Bay Technologies And 2 Yield-Generating Picks

Lovesac Co (LOVE) Earnings Forecast: Future EPS & Revenue Growth Estimates

Lovesac Co (LOVE) has an earnings forecast score of 8.33, ranking 3rd in the Household Goods industry, with an average price target of $29.00 from analysts. The stock is currently rated as a "Buy" by 6 analysts, who predict a 35.62% upside. Expected revenue …

Compare LOVABLE LINGERIE with

AppLovin Stock Tanks 15% as Q3 Outlook Misses Wall Street Expectations

Clover Health (CLOV) Stock Reprices As Profitability Finally Starts To Stick

Clover Health Investments (CLOV) Turned Profitable And Raised Guidance, Is The Stock Still Cheap?

Acciones de AppLovin caen tras resultados de Q2: ¿comprar en la caída o vender en la subida?

AppLovin (APP) Tumbled After Earnings, Is It Now A Bargain?

AppLovin Earnings: Slight Miss Is Punished Hard, but We See Strength in the Big Picture

AppLovin shares dropped nearly 20% after the company reported second-quarter revenue and adjusted EBITDA that narrowly missed management's guidance. The shortfall was attributed to a slower-than-normal pace of model improvements. Despite this miss, the article suggests strength in the broader picture for AppLovin.

AppLovin Second-Quarter Revenue Misses Street Views

Informe de resultados: AppLovin cae un 16% tras decepcionar en ingresos en el segundo trimestre de 2026

AppLovin stock tanks on Q2 revenue miss

Clover Health Investments (NASDAQ:CLOV) Shares Gap Up - Here's Why

AppLovin Stock Plunges To 52-Week Low After Earnings. Here's What Wall Street Is Saying.

Earnings call transcript: Clover Health tops Q2 2026 forecasts, shares jump after hours

Clover Health Investments earnings beat by $0.01, revenue topped estimates By Investing.com

Resultados trimestrales: AppLovin registra un beneficio por acción de 3,76 USD en el segundo trimestre, en línea con las previsiones

Clover Health Investments, Corp. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:CLOV) 2026-08-05

Clover Health Stock And 2 Penny Stocks Backed By Strong Balance Sheets

Clover Health Investments (NASDAQ:CLOV) Posts Quarterly Earnings Results, Beats Estimates By $0.01 EPS

AppLovin, 2T fiscal 2026: ingresos +53% y margen de EBITDA ajustado: 84%